Moderna Inc. buy UBS Group AG
Start price
19.02.25
/
50%
€34.80
Target price
19.02.26
€74.74
Performance (%)
21.67%
End price
20.02.26
€42.34
Summary
This prediction ended on 20.02.26 with a price of €42.34. The BUY prediction by UBS_Group_AG finished with a performance of 21.67%. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 18.109% | 18.109% | 140.252% |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $96.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten